Journal of Cancer Research and Clinical Oncology

, Volume 117, Issue 5, pp 416–420 | Cite as

Effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines

  • Y. Takeda
  • M. J. Escribano
Original Papers Experimental Oncology

Summary

The effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines, BxPC-3 and SOJ-6, were studied. The BxPC-3 cell line (American Type Culture Collection no. CRL 1687) was derived from a moderately differentiated pancreatic adenocarcinoma. The SOJ-6 cell line is a subclone of SOJ that was initiated from ascites of a well-differentiated pancreatic adenocarcinoma. Both cell lines express fetoacinar pancreatic antigen, an antigen that might be associated with early transformation stages. However, these lines have different proliferation and tumoral powers. SOJ-6 cells showed an almost twofold higher division rate over BxPC-3 cells when cultured in RPMI-1640 medium containing 10% fetal bovine serum. The tumorigenic degree of SOJ-6 cells, as assessed by tumor growth in nude mice, was about three times greater than that of BxPC-3. The in vitro growth of BxPC-3 cells was significantly promoted by insulin, and was slightly inhibited by somatostatin, whereas the growth of SOJ-6 cells was not influenced by these hormones. Using a clonogenic assay in soft agar, the average ratio of colony numbers formed by SOJ-6 and BxPC-3 was about 10/1, indicating a good correlation between the colony formation and tumorigenic degree in vivo. In this test, the number of colonies formed by BxPC-3 cells was increased about twofold in insulin-supplemented medium. On the other hand, somatostatin inhibited the colony formation by a factor of four to six. However, no hormonal modulation of the colony formation of SOJ-6 cells was observed. Our data show that pancreatic cancer cell lines respond differently to pancreatic hormones, and suggest that this may be correlated to a tumour stage or a tumour type.

Key words

Pancreas cancer Insulin Somatostatin Growth Colony formation 

Abbreviations

FAP antigen

fetoacinar pancreatic antigen

FBS

fetal bovine serum

PBS

phosphate-buffered saline

RPMI-1640

Roswell Park Memorial Institute's Medium 1640

CEA

carcinoembryonic antigen

CA 19-9

carbohydrate antigen 19-9

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albers GHR, Escribano MJ, Daher N, Nap M (1990) FAP protein in the normal pancreas, chronic pancreatitis, pancreatic adenocarcinoma and intraabdominal metastasis of adenocarcinomas. An immunological study. Am J Clin Pathol 93:14–20Google Scholar
  2. Bockman DE (1981) Cells of origin of pancreatic cancer: experimental animal tumors related to human pancreas. Cancer 47:1528–1534Google Scholar
  3. Carre-Llopis A, Loridon-Rosa B, Escribano M (1987) Ultrastructual changes in acinar cells of hamster pancreas in chemically induced carcinogenesis. Cell Biol Int Rep 11:no.9Google Scholar
  4. Eriguchi M, Carre-Llopis A, Orbach-Arbouys S, Escribano MJ (1987) Evolution of expression of fetal acinar antigens during carcinogenesis of the pancreas of hamster: individual follow-up by open biopsy. JNCI 78:519–525Google Scholar
  5. Escribano MJ, Carre-Llopis A, Loridon-Rosa B (1985) Expression of oncofetal pancreatic antigens in hamster adult pancreas during experimental carcinogenesis. Br J Cancer 51:187–193Google Scholar
  6. Faivre J, Bedenne L, Arveux P, Klepping C (1990) Epi-démiologie descriptive du cancer du pancréas. Bull Cancer 77:39–46Google Scholar
  7. Flaks B, Moore MA, Flaks A (1982) Ultrastructual analysis of pancreatic carcinogenesis: V. Changes in differentiation of acinar cells during chronic treatment withN-nitrosobis(2-hydroxypro-phyl) amine. Carcinogenesis 3:485–498Google Scholar
  8. Fujii Y, Sekiguchi M, Shiroko Y, Shimizu H, Sugawara I, Hasumi K, Eriguchi M, Ikeuchi T, Uchida H (1990) Establishment and characterization of human pancreatic adeno-carcinoma cell line SOJ producing carcinoembryonic antigen and carbohydrate antigen 19-9. Hum Cell 3:31–36Google Scholar
  9. Gonzalez-Barcena D, Rangel-Garcia NW, Perez-Sanchez PL et al. (1986) Response to D-Trp-6-LH-RH in advanced adeno-carcinoma of pancreas. Lancet 2:154Google Scholar
  10. Lhoste EF, Roebuck BD, Stern JE, Longnecker DS (1987) Effect of orchiectomy and testosterone on the early stages of azaserine-induced pancreatic carcinogenesis in the rat. Pancreas 2:38–43Google Scholar
  11. Lieberman I, Ove P (1959) Growth factors for mammalian cells in culture. J Biol Chem 234:2754Google Scholar
  12. Longnecker DS (1990) Experimental pancreatic cancer: role of species, sex and diet. Bull Cancer 77:27–37Google Scholar
  13. Macpherson I, Montagnier L (1964) Agar suspension cultures for the selective assay of cells transformed by polyoma virus. Virology 23:291–294Google Scholar
  14. Mazo A, Fujii Y, Shimotake J, Escribano MJ (1991) Expression of FAP protein in the pancreatic human tumor cell line BxPC-3. Pancreas 6:37–45Google Scholar
  15. Mossner J, Logsdon CD, Goldfine ID, Williams JA (1984) Regulation of pancreatic acinar cell insulin receptors by insulin. Am J Physiol 247:155–160Google Scholar
  16. Paz-Bouza JI, Redding TW, Schally AV (1987) Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone. Proc Natl Acad Sci USA 84:1112–1116Google Scholar
  17. Popiela H, Moore W (1989) Proliferation of immunocytochemically identified islet beta cells in culture: effect of growth factors, hormones, and nutrients. Pancreas 4:244–248Google Scholar
  18. Poston GJ, Townsend Jr CM, Rajaraman S, Thompson JC, Singh P (1990) Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice. Pancreas 5:151–157Google Scholar
  19. Redding TW, Schally AV (1984) Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. Proc Natl Acad Sci USA 81:248–252Google Scholar
  20. Roebuck BD, Baumgartner KJ, Thron CD (1984) Characterization of two populations of pancreatic atypical acinar cell foci induced by azaserine in the rat. Lab Invest 50:141–146Google Scholar
  21. Sakamoto C, Goldfine ID, Williams JA (1984) The somatostatin receptor on isolated acinar cell plasma membranes. J Biol Chem 259:9623–9627Google Scholar
  22. Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopes C, Pickren JW, Bzrjian R, Douglass HO, Chu TM (1986) Characterization of a new primary human pancreatic tumor line. Cancer Invest 4:15–23Google Scholar
  23. Williams JA, Goldfine ID (1985) The insulin-pancreatic acinar axis. Diabetes 34:980–986Google Scholar
  24. Zalatnai A, Schally AV (1989) Treatment ofN-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters withd-Trp-6-LH-RH and somatostatin analogue RC-160. Cancer Res 49:1810–1815Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • Y. Takeda
    • 1
  • M. J. Escribano
    • 1
  1. 1.Laboratoire d'Immunochimie, Institut de Recherches Scientifiques sur le CancerC.N.R.S.VillejuifFrance

Personalised recommendations